KDM5C safeguards the appropriate timing of early neurodevelopment
Ontology highlight
ABSTRACT: We generated human induced pluripotent cells from intellectual disability patients carrying the c.2T>C mutation in KDM5C (Called “Mutant”). We generated a paired, isogenic human iPS cell line (called “Corrected”) using CRISPR/Cas9 and PiggyBac gene-editing technologies and conducted neuronal differentiation based on “Yichen Shi et al. Nat. Protoc. 7, 1836–1846 (2012)” to define differences in gene expression between the Mutant and Corrected during neurodevelopment.
INSTRUMENT(S): Illumina HiSeq 2500
ORGANISM(S): Homo sapiens
SUBMITTER: Violetta Karwacki-Neisius
PROVIDER: E-MTAB-7551 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA